Search results for: 'research area cell cycle c myc'
-
B1088 LY2606368Target: ChkSummary: CHK1 inhibitor
-
B2092 DoxifluridineSummary: oral prodrug of the antineoplastic agent 5-fluorouracil (5-FU)
-
A2168 Dovitinib (TKI-258, CHIR-258)2 CitationTarget: FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Multitargeted RTK inhibitor
-
A5057 MGCD-265Target: VEGFR|c-METSummary: Met/Flt/Flk/Ron/Tie-2 inhibitor
-
A3016 PLX-47201 CitationTarget: RafSummary: BRAF kinase inhibitor
-
A8341 Go 6976Target: PKCSummary: PKCα/PKCβ1 inhibitor
-
N1846 Tanshinone IIATarget: AP-1|MAGLSummary: Antioxidant and anti-inflammatory reagent
-
A4019 LY-411575Summary: Gamma secretase inhibitor
-
B3179 PTC-209Target: BMI-1Summary: Bmi-1 inhibitor,cell-permeable and small-molecule
-
A3872 TH-302Summary: Hypoxia-activated prodrug,inhibits H460/HT29 cell growth